The most supported model is that pathogenic G2019S shifts the basal catalytic set-point upward, producing higher baseline phospho-Rab output while leaving the core lysosomal volume-sensing response architecture largely intact. In this view, mutant cells begin from a higher activity floor, and the key experimental discriminator is whether baseline-normalized EC50, slope, or Emax materially increase during graded swelling.
1. **Title:** `G2019S raises the LRRK2 kinase floor more than the swelling gain`
**Mechanism:** G2019S may primarily increase constitutive catalytic output, producing higher baseline pRab10/pRa...
Skeptic
**Skeptical Read**
The main weakness across all six is the same: most cited evidence shows that mutant `LRRK2` can elevate phospho-Rab output or alter lysosomal remodeling, but it does **not** cleanl...
Domain Expert
As of **April 24, 2026**, the hypotheses that most credibly survive are:
1. **#1 Higher baseline kinase activity more than higher swelling gain**
2. **#4 Amplification is context-dependent and strong...
Synthesizer
{
"ranked_hypotheses": [
{
"title": "G2019S primarily raises baseline LRRK2 kinase activity rather than amplifying lysosomal swelling gain",
"description": "The most supported model ...
Therapeutic Window Exists Because Amplified Signal
4 rounds · quality: 0.80
Theorist
# Therapeutic/Mechanistic Hypotheses Addressing LRRK2 Signal Amplification vs. Baseline Elevation
---
## Hypothesis 1: G2019S Acts as a Lysosomal Volume-Sensing Amplifier via Enhanced RAB29-Dependen...
Skeptic
# Critical Evaluation of LRRK2 Hypotheses
## Overview
The core question—whether G2019S increases signal amplification during lysosomal swelling versus merely elevating the baseline activity floor—re...
Domain Expert
# Feasibility Assessment: LRRK2 G2019S Signal Amplification vs. Baseline Elevation Hypotheses
## Executive Summary
The core mechanistic question—whether LRRK2 G2019S drives pathology through amplifi...